title: Altered mRNP granule dynamics in FTLD pathogenesis.
abstract: In neurons, RNA-binding proteins (RBPs) play a key role in post-transcriptional gene regulation, for example alternative splicing, mRNA localization in neurites and local translation upon synaptic stimulation. There is increasing evidence that defective or mislocalized RBPs - and consequently altered mRNA processing - lead to neuronal dysfunction and cause neurodegeneration, including frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Cytosolic RBP aggregates containing TAR DNA-binding protein of 43 kDa (TDP-43) or fused in sarcoma (FUS) are a common hallmark of both disorders. There is mounting evidence that translationally silent mRNP granules, such as stress granules or transport granules, play an important role in the formation of these RBP aggregates. These granules are thought to be 'catalytic convertors' of RBP aggregation by providing a high local concentration of RBPs. As recently shown in vitro, RBPs that contain a so-called low-complexity domain start to 'solidify' and eventually aggregate at high protein concentrations. The same may happen in mRNP granules in vivo, leading to 'solidified' granules that lose their dynamic properties and ability to fulfill their physiological functions. This may result in a disturbed stress response, altered mRNA transport and local translation, and formation of pathological TDP-43 or FUS aggregates, all of which may contribute to neuronal dysfunction and neurodegeneration. Here, we discuss the general functional properties of these mRNP granules, how their dynamics may be disrupted in frontotemporal lobar degeneration/amyotrophic lateral sclerosis, for example by loss or gain of function of TDP-43 and FUS, and how this may contribute to the development of RBP aggregates and neurotoxicity. In this review, we discuss how dynamic mRNP granules, such as stress granules or neuronal transport granules, may be converted into pathological aggregates containing misfolded RNA-binding proteins (RBPs), such as TDP-43 and FUS. Abnormal interactions between low-complexity domains in RBPs may cause dynamic mRNP granules to solidify and become dysfunctional. This may result in a disturbed stress response, altered mRNA transport and local translation, as well as RBP aggregation, all of which may contribute to neuronal dysfunction and neurodegeneration.
authors.affiliation: Graduate School of Systemic Neurosciences (GSN), Planegg-Martinsried, Germany.
authors.forename: Hilary A
authors.initials: HA
authors.lastname: Bowden
authors.affiliation: BioMedical Center (BMC), Ludwig-Maximilians-University Munich, Planegg-Martinsried, Germany.|Graduate School of Systemic Neurosciences (GSN), Planegg-Martinsried, Germany.|Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
authors.forename: Dorothee
authors.initials: D
authors.lastname: Dormann
mesh_terms: D000690:Amyotrophic Lateral Sclerosis / Q000235:genetics / Q000473:pathology; D003594:Cytoplasmic Granules / Q000235:genetics* / Q000473:pathology*; D057174:Frontotemporal Lobar Degeneration / Q000235:genetics* / Q000473:pathology*; D006801:Humans; D034702:RNA-Binding Protein FUS / Q000235:genetics / Q000378:metabolism; D057177:TDP-43 Proteinopathies / Q000235:genetics / Q000378:metabolism; D020394:Vault Ribonucleoprotein Particles / Q000235:genetics* / Q000378:metabolism
chemical_list: D034702:RNA-Binding Protein FUS; D020394:Vault Ribonucleoprotein Particles
keywords: ALS; FTLD; FUS/TLS; TDP-43; mRNP granules; stress granules